Oramed Pharmaceuticals Inc. (ORMP)

USD 2.4

(2.13%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue 2.7 Million 2.7 Million 2.71 Million 2.7 Million 2.44 Million 2.45 Million
Cost of Revenue - - 90 Thousand 90 Thousand 86 Thousand 187 Thousand
Gross Profit 2.7 Million 2.7 Million 2.62 Million 2.61 Million 2.36 Million 2.26 Million
Operating Expenses 43.3 Million 26.92 Million 14.46 Million 17.24 Million 16.06 Million 13.04 Million
Selling, General and Administrative Expenses 15.66 Million 5.93 Million 4.23 Million 3.72 Million 4.08 Million 2.75 Million
Research and Development Expenses 27.63 Million 20.98 Million 10.23 Million 13.52 Million 11.97 Million 10.28 Million
Other Expenses - - - - - -
Cost and Expenses 43.3 Million 26.92 Million 14.46 Million 17.33 Million 15.97 Million 13.22 Million
Operating Income -40.59 Million -24.22 Million -11.75 Million -14.63 Million -13.52 Million -10.77 Million
Interest Expense - - - - - -
Income Tax Expense 100 Thousand -2.87 Million 192 Thousand 300 Thousand -800 Thousand 400 Thousand
Earnings before Tax -37.66 Million -22.98 Million -11.51 Million -14.05 Million -12.72 Million -10.08 Million
Net Income -37.76 Million -22.23 Million -11.51 Million -14.35 Million -12.72 Million -10.48 Million
Earnings Per Share Basic -0.97 -0.78 -0.56 -0.82 -0.86 -0.79
Earnings Per Share Diluted -0.97 -0.78 -0.56 -0.82 -0.86 -0.79
Weighted Average Shares Outstanding 38.99 Million 28.46 Million 20.53 Million 17.45 Million 14.88 Million 13.3 Million
Weighted Average Shares Outstanding (Diluted) 38.99 Million 28.46 Million 20.53 Million 17.45 Million 14.88 Million 13.3 Million
Gross Margin 1.00 1.00 0.97 0.97 1.04 0.92
EBIT Margin -13.68 -9.26 -4.17 -5.24 -5.51 -4.38
Profit Margin -13.97 -8.23 -4.25 -5.31 -5.20 -4.27
EBITDA -36.97 Million -25.03 Million -11.31 Million -14.17 Million -13.49 Million -10.75 Million
Earnings Before Tax Margin -15.02 -8.96 -4.34 -5.41 -5.52 -4.39

Income Statement Charts